Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Buy
2,339
+769
+49% +$125K 0.21% 67
2025
Q4
$306K Buy
+1,570
New +$374K 0.18% 68
2025
Q2
Sell
-1,754
Closed -$247K 64
2025
Q1
$247K Buy
1,754
+118
+7% +$19.2K 0.22% 67
2024
Q4
$273K Buy
+1,636
New +$291K 0.25% 62

Other funds holding ORCL

SharpePoint's ORCL Position: Q1 2026 in Review

SharpePoint increased its Oracle (ORCL) stake by 49% in Q1 2026, buying an estimated $125K and bringing the position to 2,339 shares worth $344K. The position accounts for 0.21% of the portfolio, ranked #67.

SharpePoint first reported a position in ORCL in Q4 2024 and has held it in 4 quarters since. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • SharpePoint held 2,339 shares of Oracle worth $344K as of Q1 2026.
  • SharpePoint bought 769 Oracle shares in Q1 2026, an estimated $125K.
  • Oracle made up 0.21% of SharpePoint's portfolio in Q1 2026, its #67 holding.
  • SharpePoint first reported a position in Oracle in Q4 2024 and has held it in 4 quarters since.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on SharpePoint's 13F filing for Q1 2026, filed 5 May 2026.